Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 3 4Phase 1 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 2Glioblastoma 2Stomach Neoplasms 1Pancreatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Mycosis Fungoides 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Head and Neck Carcinoma of Unknown Primary 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Ependymoma 1Central Nervous System Neoplasms 1Astrocytoma 1

Interventions

tislelizumab 1sintilimab 1Radiation 1Paclitaxel 1Cisplatin 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Esophageal Squamous Cell Carcinoma × Radiation × Clear all
NCT03940001 2019-09-09

A Study of Sintilimab Plus Chemoradiation Before Surgery for Esophageal Cancer

Zhejiang Cancer Hospital

Phase EARLY_PHASE1 Unknown
20 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡